期刊文献+

血清肝细胞生长因子测定对不稳定性心绞痛患者的临床意义 被引量:2

Clinical Significance Serum Hepatocyte Growth Factor Concentration in Patients With Unstable Angina Pectoris
下载PDF
导出
摘要 目的 :探讨不稳定性心绞痛 (UA)患者血清肝细胞生长因子 (HGF)水平变化的临床意义。方法 :用酶联免疫吸附法 (ELISA)测定比较不稳定性心绞痛组 (UA组 ,n =5 0 )、稳定性心绞痛组 (SA组 ,n =3 0 )和对照组 (n =3 0 )心绞痛发作 2 4小时内及治疗 2周后血清HGF水平 ,其中UA组又根据冠状动脉 (冠脉 )造影时冠脉对硝酸甘油的反应分为有固定狭窄患者与无固定狭窄患者两部分。结果 :UA组入院 2 4小时内血清HGF水平比对照组和SA组均高 [( 1674 5 4± 14 5 0 0 3 ) pg/ml对 ( 64 8 90±115 2 0 )pg/ml和 ( 72 8 5 3± 2 88 14 ) pg/ml] ,有非常显著差异 (P <0 0 1) ,而且血清HGF水平与UA分型有关 ,UA组无固定狭窄患者血清HGF水平显著低于有固定狭窄患者 [( 848 44± 14 6 49)对 pg/ml( 185 5 88± 15 44 0 7)pg/ml,P <0 0 1]。UA组发病 2周后血清HGF水平由 ( 1674 5 4± 14 5 0 0 3 ) pg/ml下降至 ( 880 71± 2 0 1 75 ) pg/ml(P <0 0 1) ;其中UA组在 3个月内发生冠脉事件的 5例患者 2周后的血清HGF水平平均为 ( 15 46 80± 93 2 12 ) pg/ml,明显高于UA组患者的平均水平 ( 880 71± 2 0 1 75 ) pg/ml(P <0 0 1)。SA组经治疗后血清HGF水平变化不大 (P >0 0 5 )。结论 :UA患者血清HGF动态升高 ; Objective: To explore the clinical significance of changes of serum hepatocyte growth factor(HGF) level in patients with unstable angina pectoris (UA). Methods: The serum HGF concentration was determined in 50 UA patients,30 patients with stable angina pectoris (SA) and 30 healthy controls by ELISA. Results: The level of serum HGF in patients with UA 1 674.54±1 450.03 pg/ml was not only significantly higher than in the controls 648.90±115.20 pg/ml ( p <0.01) or SA patients 728.53±288.14 pg/ml ( p <0.01),but also related to the UA sub-types . The HGF level in patients with coronary artery spasm 848.44±146.49 pg/ml was lower than in those with coronary artery stenosis 1 855.88±1 544.07 pg/ml ( p <0.01).The serum HGF level in UA patients decreased 2 weeks after treatment to 880.71±201.75 pg/ml ( p <0.01),but still higher than that of SA or control group. Five patients who had coronary events within 3 months maintained a high serum HGF level of 1 546.80±932.12 pg/ml. Conclusion: There were dynamic changes of serum HGF level in patients with UA,and the serum HGF level was responsible for the poor prognosis.HGF level provides a serological mark for the stratification of angina risk.
出处 《中国循环杂志》 CSCD 北大核心 2004年第2期130-132,共3页 Chinese Circulation Journal
基金 20 0 0年上海市医学发展基金重点研究课题资助项目 (2 0 0 0IZD0 0 2 )
关键词 肝细胞生长因子 不稳定型心绞痛 动脉粥样硬化 酶联免疫吸附法 Hepatocyte growth factor Aangina pectoris,unstable Atherosclerosis
  • 相关文献

参考文献5

  • 1Ueda H, Imazu M, Hayashi Y, et al. Immunohistochemical analysis of hepatocyte growth factor in human coronary atherectomy specimens: comparison with transforming growth factor beta isoforms. Virchows Arch,1997, 430:407-415.
  • 2Zhu Y, Hojo Y, Ikeda U, et al. Production of hepatocyte growth factor during acute myocardial infarction. Heart, 2000,83:450-455.
  • 3Sato T, Yoshinouchi T, Sugimoto T, et al. Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes. Jpn Circ J, 1999,63:583-588.
  • 4Nakamura Y, Morishita R, Higaki J, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun, 1995, 215: 483-488.
  • 5Luigi M, Giovannal L, Rita L, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Clin Invest Rep, 1998,11:855-859.

同被引文献12

  • 1刘文卫,唐其柱,刘永胜,朱锐,付度关,汤永谦,陶红,李素珍,叶剑文.冠脉介入治疗术对冠心病患者C-反应蛋白、肿瘤坏死因子α和肌钙蛋白Ⅰ的影响[J].中国医药导刊,2004,6(5):348-349. 被引量:2
  • 2Morishita R, Aoki M, Yo Y, et al. Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. Endocr J, 2002; 49:273 - 284.
  • 3Taniyama Y, Morishita R, Aoki M, et al. Angiogenesis and antifibtotic action by hepatocyte growth factor in cardiomyopathy. Hypertension, 2002; 40( 1 ) : 47 - 53.
  • 4Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand Factor, C - Reactive Protein, and 5 - Year Mortality in Diabetic and Nondiabetic Subjects: The Hoom Study. Arterioscler Thromb Vasc Biol, 1999; 19(12) :3071-3078.
  • 5Morishita R, Nakarnura S, Nakmmlra Y, et al. Potential role of an endothelium- specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes, 1997;46(1) : 138 - 142.
  • 6Zhu Y, Hojo Y, Ikeda U, et al. Production of hepatocyte growth factor during acute myocardial infarction. Heart, 2000; 83 : 450 - 455.
  • 7Bogaty P, Poirier P, Simard S, et al. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long- standing stable angina. Circulation, 2001; 103(25):3062- 3068.
  • 8Pietila KO, Harmoinen AP, Jokiniitty J, et al. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow - up in patients under thrombolytic treatment. Eur Heart J, 1996; 17(9) : 1345 - 1349.
  • 9迟东升.D-二聚体在心血管疾病中的应用价值[J].心血管病学进展,1998,19(1):18-20. 被引量:15
  • 10刘广芬,王晴川,陈清澄,刘必雄.尖吻蝮(Agkistrodon acutus)蛇毒凝血酶样酶的分离、纯化及其生化药理研究[J].福建医学院学报,1989,23(4):303-309. 被引量:48

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部